Financials

News Ideas Discussions Technicals Forecast Seasonals Options

KYTX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to Kyverna Therapeutics, Inc. operating, investing, and financing activities

KYTX free cash flow for Q4 24 is -37.59 M USD. For 2024, KYTX free cash flow was -116.45 M USD and operating cash flow was -114.25 M USD.

Q4 '22

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—